COM:CELYAD
Celyad Oncology
- Stock
0.53
−3.28%
−0.02
Last Close
0.55
31/03 15:35
Market Cap
11.14M
Beta: -
Volume Today
13.66K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -16.45M - | -29.11M 76.95% | -23.61M 18.92% | -43.12M 82.66% | -37.43M 13.20% | -28.63M 23.50% | -17.20M 39.91% | -26.51M 54.10% | -40.94M 54.40% | -8.45M 79.36% | |
depreciation and amortization | 870K - | 1.03M 18.74% | 1.52M 46.76% | 9.00M 493.93% | 1.11M 87.63% | 1.79M 60.50% | 1.83M 2.46% | 1.52M 17.03% | 1.44M 5.26% | 794K 44.86% | |
deferred income tax | -539K - | -6K 98.89% | -168K 2,700% | 85K - | 1.05M 1,134.12% | -531K 150.62% | |||||
stock based compensation | 1.10M - | 795K 27.60% | 2.85M 258.11% | 2.57M 9.76% | 3.60M 39.94% | 2.77M 22.81% | 2.78M 0.25% | 2.17M 21.93% | 1.62M 25.23% | ||
change in working capital | 28K - | 1.72M 6,039.29% | -1.76M 202.27% | -21.30M 1,111.72% | 481K 102.26% | -609K 226.61% | -2.87M 371.92% | 1.41M 148.89% | -4.01M 385.77% | -6.50M 61.84% | |
accounts receivables | -2.05M - | 653K 131.88% | -1.02M 255.90% | -832K 18.27% | -1.46M 75.36% | -1.77M 21.45% | |||||
inventory | 3.31M - | -481K 114.51% | 1.77M 468.40% | ||||||||
accounts payables | 1.07M - | -740K 169.42% | -2.48M 235.41% | 1.94M 178.16% | 1.16M 40.05% | -1.73M 248.41% | 2.96M 271.73% | -4.32M 245.78% | |||
other working capital | 2.08M - | -17.99M - | -1.77M - | -1.15M 35.21% | -1.56M 35.80% | 306K 119.63% | -6.50M 2,223.53% | ||||
other non cash items | -2.42M - | -1.73M 28.45% | -3.52M 103.64% | 3.30M 193.67% | 4.99M 51.15% | -3.61M 172.35% | -13.25M 267.14% | -4.70M 64.55% | 13.88M 395.42% | -1.05M 107.57% | |
net cash provided by operating activities | -17.41M - | -27.30M 56.79% | -24.69M 9.56% | -49.55M 100.66% | -27.25M 45.00% | -28.20M 3.50% | -27.66M 1.90% | -26.64M 3.69% | -28.01M 5.13% | -15.20M 45.73% | |
investments in property plant and equipment | -640K - | -838K 30.94% | -1.78M 112.65% | -858K 51.85% | -1.76M 105.71% | -622K 64.76% | -319K 48.71% | -393K 23.20% | -123K 68.70% | -934K 659.35% | |
acquisitions net | -1.50M - | -5.19M 245.73% | -1.56M 69.92% | -5.11M 227.37% | 932K 118.25% | 235K - | 6M - | 1.34M 77.65% | |||
purchases of investments | 372K - | -5M 1,444.09% | -34.23M 584.60% | -10.75M 68.60% | -26.56M 147.10% | -476K - | |||||
sales maturities of investments | 372K - | 333K 10.48% | 7.34M 2,103.60% | 34.33M 367.78% | 28.86M 15.93% | 9.38M 67.50% | 241K 97.43% | 1.09M - | |||
other investing activites | -372K - | 77K - | 5.11M 6,533.77% | -858K 116.80% | 230K 126.81% | 476K 106.96% | 267K 43.91% | 235K 11.99% | |||
net cash used for investing activites | -1.77M - | -10.69M 504.69% | -30.16M 182.08% | 22.72M 175.34% | 607K 97.33% | 8.99M 1,380.56% | 157K 98.25% | -126K 180.25% | 7.20M 5,815.87% | 407K 94.35% | |
debt repayment | -138K - | -188K 36.23% | -399K 112.23% | -576K 44.36% | -749K 30.03% | -1.49M 98.53% | -1.45M 2.69% | -1.14M 21.49% | -896K 21.13% | ||
common stock issued | 25.30M - | 109.15M 331.35% | 625K - | 43.01M 6,781.76% | 16.45M 61.76% | 36.57M - | 9.49M - | ||||
common stock repurchased | -124K - | ||||||||||
dividends paid | |||||||||||
other financing activites | 2.59M - | 1.57M 39.42% | 3.43M 118.61% | 556K 83.79% | 1.67M 199.64% | 3.31M 98.98% | 6.84M 106.43% | 4.09M 40.25% | 4.26M 4.21% | 10K 99.77% | |
net cash used provided by financing activities | 27.76M - | 110.53M 298.22% | 3.03M 97.26% | 605K 80.04% | 43.93M 7,160.83% | 18.28M 58.40% | 5.40M 70.47% | 39.52M 632.41% | 3.24M 91.80% | 9.36M 188.65% | |
effect of forex changes on cash | 1K - | 1K 0% | 1.12M 111,900% | 3K 99.73% | -265K 8,933.33% | 8K 103.02% | 32K 300% | -6K 118.75% | |||
net change in cash | 8.57M - | 72.54M 745.97% | -51.82M 171.43% | -25.10M 51.55% | 17.29M 168.87% | -1.20M 106.96% | -22.10M 1,735.88% | 12.78M 157.84% | -17.57M 237.46% | -5.44M 69.04% | |
cash at beginning of period | 19.06M - | 27.63M 44.99% | 100.17M 262.52% | 48.36M 51.73% | 23.25M 51.91% | 40.54M 74.35% | 39.34M 2.97% | 17.23M 56.19% | 30.02M 74.18% | 12.45M 58.54% | |
cash at end of period | 27.63M - | 100.17M 262.52% | 48.36M 51.73% | 23.25M 51.91% | 40.54M 74.35% | 39.34M 2.97% | 17.23M 56.19% | 30.02M 74.18% | 12.45M 58.54% | 7.00M 43.72% | |
operating cash flow | -17.41M - | -27.30M 56.79% | -24.69M 9.56% | -49.55M 100.66% | -27.25M 45.00% | -28.20M 3.50% | -27.66M 1.90% | -26.64M 3.69% | -28.01M 5.13% | -15.20M 45.73% | |
capital expenditure | -640K - | -838K 30.94% | -1.78M 112.65% | -858K 51.85% | -1.76M 105.71% | -622K 64.76% | -319K 48.71% | -393K 23.20% | -123K 68.70% | -934K 659.35% | |
free cash flow | -18.05M - | -28.14M 55.87% | -26.47M 5.92% | -50.41M 90.40% | -29.01M 42.44% | -28.82M 0.65% | -27.98M 2.91% | -27.04M 3.39% | -28.13M 4.06% | -16.14M 42.64% |
All numbers in EUR (except ratios and percentages)